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ABSTRACT
In Saccharomyces cerevisiae the FOB1 gene affects
replication fork blocking activity at the replication
fork block (RFB) sequences and promotes recomb-
ination events within the rDNA cluster. Using in vivo
footprinting assays we mapped two in vivo Fob1p-
binding sites, RFB1 and RFB3, located in the rDNA
enhancerregionandcoincidentwiththosepreviously
reported to be in vitro binding sites. We previously
provided evidences that DNA topoisomerase I is
able to cleave two sites within this region. The results
reported in this paper, indicate that the DNA topoi-
somerase I cleavage specific activity at the enhancer
region is affected by the presence of Fob1p and inde-
pendent of replication and transcription activities.
We thus hypothesize that the binding to DNA of
Fob1p itself may be the cause of the DNA topoisome-
rase I activity in the rDNA enhancer.
INTRODUCTION
The genes coding for ribosomal RNAs in Saccharomyces
cerevisiae are organized as a 9.1 kb basic unit repeated in
tandem about 100–150 times (1) coding for the 35S RNA
(further processed in 5.8S, 16S and 25S RNA), and the 5S
RNA (2). This genetic locus is transcribed by two different
specialized RNA polymerases: RNA polymerase I and RNA
polymerase III, transcribing the 35S RNA and the 5S RNA,
respectively. This locus is fundamental for yeast life, provid-
ing the whole RNA content of the ribosomal particles.
The combination of both in vitro and in vivo approaches
(3–5) has established that the DNA–proteininteractions occur-
ring in the Non-Transcribed Spacer 2 region (NTS2) (see
Figure 1), particularly at the 35S RNA promoter, are repre-
sented by a complex interplay of transcription factors acting to
stimulate RNA polymerase I activity and other proteins like
the Reb1p, or the DNA topoisomerase I enzyme, whose role
in that particular region has not been established yet. In vivo,
a ﬁne mapping was obtained for UAF, CF, Reb1p and
Top1p (5). Important events such as the termination of
RNA polymerase I transcription (6) and the block of the
DNA replication fork (7) occur at the NTS1 sequence
(reported in Figure 1) and in particular at the enhancer region
(E). However, only very recently DNA–protein interactions,
have been reported for this region. In particular, it has been
demonstrated (8) that Sir2p, Net1p and Fob1p bind to this
portion of regulatory sequences. It has also been shown that
binding occurs at the promoter region although with different
efﬁciency. The method utilized Chromatin Immunoprecipita-
tion (ChrIP), while representing one of the best analysis avail-
able to reveal site-speciﬁc DNA–protein interactions, does not
allow mapping at nucleotide level of resolution. Furthermore,
it has been shown that Fob1p can bind, in vitro, to two out of
three replication fork block (RFB) sequences (9) providing a
model for its activity in the block of the replication fork. The
importance of FOB1 gene is due to the following relevant
ﬁndings: FOB1 is required for rDNA recombination and for
its replication fork blocking activity (10) to prevent collision
between DNA replication and rDNA transcription events. In
addition, it is necessary for either contraction or expansion of
ribosomal units (11); FOB1 deletion expands life span in
yeast, also reducing the production of extrachromosomal
rDNA circles (ERCs) (12). Moreover, it is involved in the
control of transcriptional silencing occurring at the enhancer
region of rDNA (8).
In previous analyses (13), we demonstrated that DNA topoi-
somerase I speciﬁcally cleaves DNA at two sites in the enhan-
cer region and in one site at the 35S RNA promoter. Those
regions overlap with those reported to be associated with
Sir2p, Net1p and Fob1p (8).
It has been shown that DNA topoisomerase I has an active
role in both transcriptional silencing (14) and in DNA recomb-
ination of rDNA units (15,16). Strikingly, all the genes
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doi:10.1093/nar/gki950involved in these pathways share similar phenotypes with
DNA topoisomerase I. In particular, TOP1, NET1, SIR2 and
FOB1 are all connected with ribosomal silencing. SIR2 and
FOB1 are also engaged in DNA recombination of ribosomal
units together with TOP1. In order to clarify the possible role,
if any, of the DNA topoisomerase I in the ribosomal silencing
or in rDNA recombination, we evaluated the in vivo binding of
Fob1p to the rDNA locus by a high resolutionmethod.In order
to investigate the potential connection between Fob1p activity
and the DNA topoisomerase I cleavage sites, we provide evi-
dences that DNA topoisomerase I cleavage activity is depen-
dent on FOB1 in the NTS1, while FOB1 independent is in the
NTS2. We also show that events like DNA replication or
rDNA transcription do not affect the DNA topoisomerase I
site-speciﬁc reactions.
MATERIALS AND METHODS
Yeast strains, plasmids and culture media
The strains used in this study are: W303-1a (WT) (Mata, ade
2-1, ura 3-1, his 3-11,15, trp1-1, leu 2-3112, can1-100); D128-
1D (D43) (Mata, rpa43::LEU2 ade 2-101 uaa, ura 3-52, lys2-
801 uag, trp1-D63, his 3-D200, leu 2-D1/) pNOY102, kindly
provided by P. Thuriaux; Y1422 (sir2D): (Mata, Leu2-3112
ura3-52 ade8, trp1 D901 sir2::TRP1), kindly provided by
J.Broach; NOY1064 (fob1D): (Mata, ade 2-1, ura 3-1, his
3-11,15, trp1-1, leu 2-3112, can1-100, fob1::HIS3) and
NOY908 (rdnDD pPolI) (Mata, ade 2-1, ura 3-1, his 3-11,
trp1-1, leu 2-3112, can1-100 rdnDD::HIS3 carrying
pNOY373) kindly provided by M. Nomura; WY69
(net1D): (Mata, ade 2-1, ura 3-1, his 3-11,15, trp1-1, leu
2-3112, can1-100, net1::HIS5) kindly provided by D.Moazed.
RS1479 (tof2D) (Mata, ade 2-1, ura 3-1, his 3-11,15, trp1-1,
leu 2-3112, can1-100 tof2::URA3) kindly provided by
R. Sternglanz.
Culture media. The culture media utilized for all cell growths
were the complete YP (17). Addition of Glucose or Galactose
at a concentration of 3% is indicated when appropriate.
Enzymes and chemicals
Restriction enzymes and Micrococcal nuclease (MNase) were
purchased from Boehringer. DNAse I and T4 polynucleotide
kinase were purchased from Roche; Vent(exo
 ) polymerase
from New England Biolabs; Zymolyase 100T from Seikagaku,
Tokyo, Japan; a-Mating factor from Sigma-Aldrich and radio-
chemicals from Amersham.
Chromatin analysis
MNase treatments: Cells (100–200 ml grown to 0.5 OD) were
pelletted and resupended in 10 ml of a buffer containing 1 M
sorbitol,50mMTris–HCl(pH7.5),10mMb-mercaptoethanol,
in the presence of 0.05 mg/3 · 10
7 cells of Zymolyase
100T and incubated for 10 min at 30 C. The spheroplasts
were harvested, resuspended in Nystatin buffer [50 mM
NaCl, 1.5 mM CaCl2, 20 mM Tris–HCl (pH 8.0), 1 M sorbitol
and 100 mg/ml nystatin] (18) and divided into 0.25 ml aliquots.
MNase (0.2, 0.4, 0.8 and 1.6 U) was added to each aliquot
and the samples were incubated at 37 C for 15 min. The
reaction was stopped with 1% SDS and 5 mM EDTA (ﬁnal
concentrations). Proteinase K (40 mg/sample) was added
Figure 1. SchematicrepresentationofrDNAorganizationin Saccharomyces cerevisiae.( A) TherDNAcodingsequences: theblackarrowsindicatethe 35Sand5S
rRNA transcriptional initiation sites. The enhancer and ARS elements are also indicated. The bar in the upper part of the figure indicate the dimension and the
boundaries of the repeated unit. (B) Enlargement of the NTS1 and NTS2. The positions of the most important DNA elements (Enhancer, E and ARS) and the main
restrictionenzymesareindicated.ThepositionsofDNAtopoisomeraseIcleavagesiteswithintheNTS1andNTS2regionsareshown(emptyarrows).Theprobeused
forhybridization(ProbeEn)andtheoligonucleotidesusedfortheprimerextensionreactionsarealsoreported(seetextfordetails).Numberingisrelativetothe35S
RNA transcriptional start (+1).
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puriﬁed by three phenol/chloroform extractions and ethanol
precipitation. RNase treatment was also performed.
Low resolution analysis
Indirect end-labelling analysis (19) was performed as follows:
after treatment with the appropriate restriction enzymes, the
samples were electrophoresed in 1.2% agarose gels
(1.75 V/cm), transferred to BA-S 85 nitrocellulose membrane
(Schleicher & Schuell), hybridized according to standard
procedures and detected by autoradiography.
In vivo footprinting
Preparation of nuclei. Cells (150 ml grown to 0.4 OD600/ml)
were centrifuged and resupended in 10 ml of a buffer contain-
ing 1 M sorbitol, 50 mM Tris–HCl (pH 7.5) and 10 mM
b-mercaptoethanol in the presence of 0.05 mg/3 · 10
7 cells
of Zymolyase 100T and incubated for 10 min at 30 C.
Spheroplasts were then washed once with 1 M Sorbitol and
resuspended in Lysis buffer [Ficoll 18%, 20 mM K-phosphate
buffer (pH 6.8), 250 mM EDTA, 250 mM EGTA, 1 mM
Leupeptine, 1 mM phenylmethlysulfonyl ﬂuoride (PMSF),
0.15 mM Spermine and 0.5 mM Spermidine]. Nuclei were
prepared as reported with minor modiﬁcations (20).
DNAse I treatment. Nuclei were resuspended in digestion
buffer [15 mM Tris–HCl (pH 8.0), 50 mM NaCl, 1.4 mM
CaCl2, 200 mM EDTA, 200 mM EGTA, 1 mM Leupeptine,
1 mM PMSF, 0.15 mM Spermine, 0.5 mM Spermidine and
5m Mb-mercaptoethanol] and divided into 0.2 ml aliquots.
DNAse I (6 and 12 U) was added to each aliquot and the
incubation was carried out for 5 min at 0 C. The reaction
was stopped with 1% SDS, 5 mM EDTA (ﬁnal concentra-
tions). Proteinase K (40 mg/sample) was added and the
samples kept at 56 C for 2 h. The DNA was then puriﬁed
by three phenol/chloroform extractions and ethanol precipita-
tion, followed by RNase A treatment.
Induction of Camptothecin (CPT) dependent DNA
topoisomerase I cleavage sites
Spheroplasts were obtained as described above, resuspended
in cleavage buffer [3 mM CaCl2, 1 mM MgCl2, 10 mM Tris–
HCl (pH 8.0), 1 M sorbitol and nystatin 100 mg/ml] and
aliquots were incubated with 0–100–200 mM CPT for 2 min
at room temperature. The reaction was stopped with 1% SDS
and 5 mM EDTA (ﬁnal concentrations). Proteinase K
(40 mg/sample) was added and the samples kept at 56 C for
2 h. The DNA was then puriﬁed by three phenol/chloroform
extractions and ethanol precipitation, followed by RNase A.
The samples where the addition of CPT was substituted by
0.8 M NaCl (ﬁnal concentration) provide informations on
DNA integrity.
Oligonucleotide primers and probes
The following synthetic oligonucleotides were used as primers
in the extension reactions: r3: 50-CGCGTTTCCGTATTTTC-
CGC-30, r32: 50-GGGGCCTAGTTTAGAGAGAAGTAG-30.
The r3 and r32 synthetic oligonucleotides used as primers in
the extension reactions lie at positions  267/ 248 bp (r3) and
 2453/ 2430 bp (r32), respectively, from the 35S RNA
transcriptional initiation start (RIS) (sequence number +1;
see also Figure 1). According to standard procedures 50
end-labelling using [g-
32P]ATP and T4 polynucleotide kinase
was performed (21). The labelled oligonucleotides were
puriﬁed by PAGE. The probe En, annealing positions
 1705/ 1458 bp, from the RIS was labelled by random
priming.
Multiple-round primer extension and detection
of DNAse I footprintings and DNA
topoisomerase I cleavage sites
Genomic DNA (0.1/0.2 mg) were reacted with 5 U of Vent
polymerase and 100000 c.p.m. of end-labelled oligonucleo-
tide (speciﬁc activity1–2 mCi/pmol). The samples were cycled
ﬁve times through the following steps: 95 C for 5min, 63 Co r
70 C (for r32 and r3, respectively) for 10 min and 76 C for
3 min. The extension products were phenol extracted, ethanol
precipitated, dissolved in formamide and dyes, and analysed in
6% denaturing polyacrylamide gel. The DNAse I footprints
were detected by autoradiography.
RESULTS
In vivo Fob1p-binding sites are located in the
surrounding region where DNA topoisomerase I
cleaves the NTS1
In order to clarify whether the localization of the SIR2, NET1
and FOB1 gene products [reported to bind to the rDNA in the
NTS1 and NTS2, (8)] may interfere with the site-speciﬁc
activity of DNA topoisomerase I, described for the same
regions (13), we evaluated the in vivo binding, at the nucle-
otide level, of the only protein capable to bind DNA: Fob1p
(9). To accomplish this task we set up an in vivo footprinting
assay by DNAse I, as described previously (22). WT and
fob1D cells were grown in rich medium to the exponential
phase (0.4 OD/ml); nuclei were prepared [as in ref. (1)] and
aliquots were subjected to digestion with different amounts of
DNAse I (Figure 2A). After the in vivo enzymatic treatment,
DNA was extracted and puriﬁed. The digestion products
were subjected to a primer extension with a [g-
32P]ATP
labelled oligonucleotide (r32, see map in Figure 1), annealing
from the position  2453 to the position  2429, numbering
from the transcriptional start site of 35S RNA (+1). The
primer extension reactions were conducted in PCR conditions
(see Materials and Methods). The linear ampliﬁcation pro-
ducts were puriﬁed, separated by sequencing gel (23) and
visualized by autoradiography. Mapping of footprinted posi-
tions was obtained comparing the digestion pattern of the
samples with the molecular weights (M, in Figure 2) and
the sequencing ladders (A, C in Figure 2). As reported in
Figure 2, the comparison between the DNAse I digestion
proﬁles of WT and fob1D samples, reveals interesting differ-
ences represented by enhanced (empty arrowheads) and pro-
tected (ﬁlled arrowheads) regions, strongly supporting that, in
vivo, site-speciﬁc factor(s) are bound to rDNA. In fact at
positions  2232 and  2220 two protections appear; at the
30 of this protected region, (position  2200) a clear enhance-
ment is also present. We identiﬁed the region encompassing
these three sites as ‘a’ (see Figure 2C). Furthermore, three
additional DNA sites show differences between the two
Nucleic Acids Research, 2005, Vol. 33, No. 19 6329digestion proﬁles: positions  2119 and  2109 are protected
while a strong enhancement is present at position  2097. We
named the region encompassing these three sites as ‘b’.
Conversely all the remaining DNA regions show the same
DNAse I pattern in the two strains. In order to better evaluate
the different DNAse I digestion proﬁles occurring in these
regions (‘a’ and ‘b’) we enlarged the gel area reported in
Figure 2A0. The protections/enhancements proﬁle between
regions ‘a’ and ‘b’ clearly describes the speciﬁc interaction(s)
ofputative protein(s) in WT cells, as comparedto fob1D strain.
Since the two strains differ exclusively for the presence of
the FOB1 gene (shown in Figure 2) it is high likely that
the regions ‘a’ and ‘b’ correspond to Fob1p-binding sites
in vivo. In addition, comparing the data obtained in vitro
with the HindIII–HpaI portion of the NTS1 sequence and
the puriﬁed protein, a close match with our ﬁndings is notice-
able (9). In fact, the ‘a’ region reported in Figure 2 overlaps
with RFB3 (from  2232 to  2200 in vivo and from  2213 to
 2203 in vitro) and the region reported as ‘b’ overlaps with
RFB1 (from  2119 to  2097 in vivo and from  2129 to
Figure 2. Detection of Fob1p footprinting and DNA topoisomerase I cleavage sites in the NTS1 region. (A) High resolution analysis of in vivo Fob1p footprinting.
ComparisonbetweenWTandFOB1mutant.Startingfrompurifiednuclei,chromatinwasdigestedinvivowith0–6–12UofDNAseIfor50 at0 C(lanesU,1and2for
WTandU,4and5forfob1mutant,respectively);afterDNApurificationthesampleswereprimerextendedwiththelabelledoligonucleotider32(seeMaterialsand
MethodsandFigure1formappositionanddetails).LaneM:sizemarker(pBR322/MspI);laneA,C:sequencinglanes;laneU:untreatedsamples.Protectedareasare
indicatedbyfilled arrowheads whileenhancedbandsare shownby emptyarrowheads;triangles indicateincreasingamountofDNAse I in thetreatment. Region‘a’
and‘b’whereFob1pfootprintsDNAintheNTS1regionarealsoreported.(A0)EnlargementoftheNTS1regionencompassingregions‘a’and‘b’.Enhancementsand
protection within the ‘a’ and ‘b’ regions are indicated by empty and filled arrowheads, respectively. (B) High resolution analysis of in vivo DNA topoisomerase I
cleavagesiteswithintheNTS1regioninWTstrainandtop1Dstrains.LanesCPTandDNAfromWTortop1D.Spheroplaststreatedinvivowith50mMCPT;laneU:
spheroplastswithout treatmet of CPT; lane NaCl: spheroplastspre-treated with 0.8 M NaCl. All sampleswere primerextended by Vent (exo
 ) DNA polymerase in
PCRconditions,startingfrom50 labelledoligor32(forthepositionsee Figure1).M:sizemarker(pBR322/MspI);laneAandC:sequencinglanes.Thecanonictwo
previouslymappedDNAtopoisomeraseIcleavagesitesintheNTS1regionareindicatedbyfilledarrawheads.Numberingreferstothe35Stranscriptionalstart(+1).
(C) Schematic representation of the overlapping in vivo and in vitro Fob1p-binding regions. This portion of the NTS1 sequence encompasses the three RFBs
(underlinedandbold).Strong(F1andF4)andweak(F2andF3)Fob1p-bindingsequencespreviouslymappedinvitro(15)arerepresentedbyemptythinrectangles.
Regions ‘a’ and ‘b’ [corresponding to the ‘a’ and ‘b’ areas in (A) and (A0)], are here indicated by filled thin rectangles. Empty and filled arrowheads represent
enhancements and protections respectively, mapped as reported in (A). Positions of the CPT dependent DNA topoisomerase I cleavage sites in the NTS1
[corresponding to those indicated by filled arrowheads in (B)] are also indicated. All numbering refers to the 35S transcriptional start and starts from RNA
initiation site (+1).
6330 Nucleic Acids Research, 2005, Vol. 33, No. 19 2113 in vitro. See also the scheme reported in the bottom of
Figure 2C).
In order to show the strong overlapping between the in vivo
Fob1p-binding sequences and DNA topoisomerase I speciﬁc
cleavage sites in the NTS1 [observed previously, (13)], we
treated WT cells with CPT, a speciﬁc DNA topoisomerase IB
inhibitor (24). Spheroplasts obtained from WT or top1D cells
(as reported previously) were permeabilized by nystatin (18)
and treated with 0.8 M NaCl in order to remove most of the
DNA topoisomerase molecules bound to DNA and to show the
basal level of DNA integrity without the DNA topoisomerase I
nicking activity. The DNA from treated cells was puriﬁed as
reported (13) and subjected to primer extension in the same
condition employed for the DNAse I treated samples. The
puriﬁed material was loaded on a sequencing gel and the
separated fragments were revealed by gel autoradiography.
As reported in Figure 2B, the two major cleavage sites
lie very close to the footprinted regions observed with the
DNAse I analysis (compare Figure 2A and B) while in the
top1D strain no cleavage production is observed.
The arrowhead labelled as  2143 in Figure 1 indicates the
cleavage site located at the 50 of the region ‘b’ (reported in the
graphical representation of Figure 2C); this map position is
quite different from that shown in a previous report (13): the
site is actually the same but the attribution of map position was
corrected by shifting 45 bp away from the 35S RNA transcrip-
tional start, used as numbering reference. The other cleavage
site, occurring at position  2236, at the 50 of the region ‘a’
(Figure 2C) is also indicated by an arrowhead.
Previous experiments (8) have demonstrated, by ChrIP, that
Sir2p, Net1p and Fob1p are bound to NTS1 and NTS2
sequences. In order to verify whether the Fob1p-binding on
RFB sequences is maintained in sir2D or net1D strains we
performed in vivo DNAse I footprinting in these mutants.
We found that the two regions of Fob1p-binding (‘a’ and
‘b’) are still perturbed in the DNAse I digestions compared
to the naked DNA proﬁle (data not shown); therefore we can
conclude that Fob1p-binding to the ‘a’ and ‘b’ regions is SIR2
and NET1 independent.
From the data reported so far, we can conclude that Fob1p-
binding in vivo and in vitro (9) coincide, that the binding is
SIR2 and NET1 independent, and that these speciﬁc-sites are
nearly overlapping with the cleavage sites produced, in vivo,
by DNA topoisomerase I.
The DNA topoisomerase I cleavage sites of the
enhancer region are FOB1 dependent
Given the strict colocalization of the Fob1p footprintings
(Figure 2A) and the DNA topoisomerase I cleavage sites
on the enhancer region of the rDNA locus (Figure 2B), and
considering the colocalization of Sir2p, Net1p and Fob1p
described previously (8), we wondered whether the DNA
topoisomerase I cleavage sites are correlated with the presence
of SIR2, NET1 or FOB1 functioning genes.
Thus, we studied the cleavage sites of DNA topoisomerase I
in different strains lacking these genes. We assayed, by CPT
blocking of DNA topoisomerase I activity, both the enhancer
and the promoter regions in WT, sir2D, fob1D and net1D cells
(Figure 3A and B, respectively). In the enhancer region, the
characterization of the cleavage sites was obtained by primer
extension using the oligonucleotide r32 (see map in Figure 1).
Samples reported as U correspond to untreated cells and show
the cleavage efﬁciency of DNA topoisomerase I in the absence
of CPT. Samples named NaCl indicate cells pre-treated with
0.8 M NaCl that prevents cleavage induction, and samples 1 to
8 represent couples of treatments with 100 and 200 mM CPT.
The results shown in Figure 3A, clearly indicate that only the
fob1D mutant completely lacks these cleavage sites, in any
tested condition (0, NaCl, 100 e 200 mM CPT, respectively)
when compared with the other three strains. Moreover, in WT,
sir2D and net1D strains a very similar pattern shows, up with
twoDNAtopoisomeraseIcleavagesites(arrowsinFigure3A),
suggesting that the presence/absence of Sir2p and Net1p does
not basically interfere with the site-speciﬁc activity of DNA
topoisomerase I in the rDNA enhancer region. We also studied
the cleavage induction in the promoter region of the 35S
rRNA, where colocalization of Sir2p, Fob1p and Net1p also
occurs (8). The same DNA preparations used for the analysis
reported in Figure 3A, were primer extended by oligonucleo-
tide r3, annealing from position  268 to position  249 from
the transcriptional start site of 35S RNA (Figure 1, for map-
ping details). The elongation products were separated by
sequencing gel electrophoresis and the bands revealed by
gel autoradiography. In the promoter region only one
speciﬁc-site at  171 bp, due to the DNA topoisomerase I
activity, is evidenced (black arrow in Figure 3B). While the
fob1D strain in the enhancer region does not show any clea-
vage site, all the four strains show comparable cleavage pat-
tern by DNA topoisomerase I in the promoter region (compare
Figure 3A and B).
Taken together, these data indicate that the DNA topoi-
somerase I site-speciﬁc activity depends on FOB1 in the
rDNA enhancer region, but it is FOB1 independent on the
promoter region. The DNA topoisomerase I activity is also
independent of the presence of Sir2p and Net1p both at the
enhancer and at the 35S RNA promoter. This observation
recalls recent ﬁndings (8) concerning the association of the
regulator of nucleolar silencing and telophase exit (RENT)
complex with the rDNA (25), where the authors described
that both this association and the ribosomal silencing are
FOB1 dependent in the enhancer region (8), while they are
independent in the promoter, suggesting the involvement of
different factor(s). It is to notice that both the DNAse I and
DNA topoisomerase I cleavage site assays, show two faint
bands in most of the untreated samples (U in Figure 2A
and Figure 3A), analysed by extension of the oligo r32. We
believe that these bands have been originated by the treatment
of the ‘U’samples (as well as all the other samples) with the
denaturing agent SDS that is used to stop the DNA topoisome-
rase I ongoing reactions (see Material and Methods for
details). This procedure induces trapping of covalent complex
of DNA topoisomerase I-DNA (26), thus revealing cleavages.
This interpretation is supported by the absence of these faint
bands inthe fob1Duntreated samples,observedintheDNAseI
(Figure 2A, lane U fob1D), and in the DNA topoisomerase I
experiments (Figure 3A, lane U fob1D), and in top1D
(Figure 2B, lane U, top1D).
We further investigated two additional aspects of the DNA
topoisomerase I site-speciﬁc cleavage reaction: (i) The reac-
tivity of the enzyme on a substrate located outside the chro-
mosome XII. In order to accomplish this we analysed a strain
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whose growth is supported by a 2 micron based plasmid carry-
ing an entire ribosomal unit including the NTS sequence,
pNOY373 (27). When cleavage sites are induced by CPT
as reported above, no difference were observed with respect
to the WT condition, suggesting that it is not the chromosomal
context that induces the DNA topoisomerase I cleavage
sites (data not shown), (ii) we asked whether the complex
Figure 3. Site-specific in vivo cleavages by DNA topoisomerase I in the NTS1 and NTS2 regions. Comparison among WT, sir2, fob1 and net1 mutants. (A) High
resolution analysis in the NTS1. Lanes 1 and 2, 3 and 4, 5 and 6, 7 and 8: spheroplasts from WT, sir2D, fob1D and net1D cells, respectively, treated in vivo with
increasing amounts (filled triangles) of CPT (100 and 200 mM, respectively). Lanes U: control spheroplastswithout CPT; lanes NaCl: spheroplasts pre-treated with
0.8MNaCl.AllsampleswereprimerextendedbyVent(exo
 )DNApolymeraseinPCRconditions,startingfrom50 labelledoligor32(forthepositionseeFigure1B).
M: size marker (pBR322/MspI); lane A and C: sequencing lanes. The schematic (not in scale) map on the right part of the Panel represents the investigated region:
positions of the two DNA topoisomerase I cleavage sites ( 2236 and  2143) are indicated by filled arrows. Numbering refers to the 35S transcriptional start (+1).
Regions‘a’and‘b’arealsorepresentedasemptyrectangles.(B)HighresolutionanalysisintheNTS2.Lanes1and2,3and4,5and6,7and8:spheroplastsfromWT,
sir2D,fob1D,net1Dcells,respectively,treatedinvivowithincreasingamounts(filledtriangles)ofCPT(100and200mM,respectively).LanesU:controlspheroplasts
withoutCPT;lanesNaCl:spheroplastspre-treatedwith0.8MNaCl.AllsampleswereprimerextendedbyVent(exo
 )DNApolymeraseinPCRconditions,starting
from50 labelledoligor3(forthemappositionseeFigure1).M:sizemarker(pBR322/MspI).Theschematic(notinscale)mapontherightpartofthePanelrepresents
the investigated region: the position of the unique DNA topoisomerase I cleavage site ( 171) produced by the enzyme in the NTS2 region is indicated by the filled
arrow. Numbering refers to the 35S transcriptional start (+1).
6332 Nucleic Acids Research, 2005, Vol. 33, No. 19Net1p-Sir2p, in association with Tof2p [all recently shown to
be present in the RENT complex, (28)] could affect the DNA
topoisomerase I cleavage. We performed the DNA topoisome-
rase I cleavage assay in a tof2D strain: no differences were
observed relative to the WT strain (data not shown), thus
conﬁrming that the RENT complex is not involved in DNA
topoisomerase I cleavage site production.
We set up a series of experiments involving the DNA rep-
lication block, the rRNA transcription suppression as well as a
chromatin structure analysis, to understand whether the DNA
topoisomerase I cleavage sites on the rDNA enhancer are to
be attributed to (i) the blocking of the replication fork over the
RFB sequences, (ii) the swivel activity necessary to release the
torsional stress created by the RNA polymerase I transcription
or (iii) an alteration of the chromatin structure.
DNA topoisomerase I activity in the rDNA enhancer
is unaffected when DNA replication is blocked or
rDNA transcription abolished
We evaluated the possibility that the RFB, exerted by Fob1p
on RFB sequences, may be the physical cause that stimulates
the site-speciﬁc activity of DNA topoisomerase I on the
 2143 and  2236 sites. In fact, the position of these sites
matches quite well with the RFB sequences (see the schematic
drawing in Figure 2C). We analysed the DNA topoisomerase I
cleavage sites after addition of 10 mg/ml of a-factor to WT
cells grown to exponential phase (0.4 OD/ml), to block cell
cycle progression and DNA replication (29). After a 2.5 h
treatment the cells were checked for bud disappearance and
processedforDNAtopoisomerase Icleavage sitesinductionas
depicted in Figure 2 and 3. The results are reported in
Figure 4A. The two cleavage sites, at position  2143 and
 2236, are present in both untreated and a-factor treated
cells suggesting that stalled forks (occurring only in the
untreated cells) are not responsible for the induction of
DNA topoisomerase I activity.
We also investigated the possibility that the collision
between the blocked forks and the transcription bubble pro-
gressing from the adjacent unit, in the rDNA cluster, could
represent a triggering event for cleavage. We studied the yeast
strain D43, lacking the A43 subunit of RNA polymerase I (30),
that is unable to support rDNA transcription. The viability of
this strain in galactose medium is allowed in the presence of an
episomal plasmid carrying a copy of the 35S RNA under the
GAL7 promoter [plasmid pNOY102, (31)]. When we induced
the DNA topoisomerase I cleavages sites, the comparison
between the WT and the D43 strains did not show any differ-
ence in the site production (Figure 4B). Both strains show a
similarpattern,suggestingthatcleavage inductionisnotdueto
the collision between blocked forks and the transcription
bubble.
The chromatin organization of both enhancer and
promoter regions does not change in the fob1D strain
An alternative explanation for the loss of DNA topoisomerase
I cleavage sites within the enhancer region in the fob1D strain
could be compatible with an altered nucleosome organization
in the strain lacking the FOB1 gene. Previously, we studied the
NTS2 region of rDNA, where we found ﬁve well positioned
nucleosomes (5). In the same study we also investigated the
Figure 4. DNA topoisomerase I cleavage sites dependence on replication and transcription activities. (A) Replication dependence. WT cells from an exponential
colture were synchronized in to S-phase by an a-factor arrest (+). WT cells from an exponential colture un-induced with a-factor were used ( ) as control. Lanes 1
and 2: spheroplasts treated in vivo with increasingamount of CPT (filled triangles) as reported for Figure 3, in absence of a-factor; lanes 3 and 4: spheroplasts from
synchronizedcellstreatedinvivowithincreasingamountsofCPT;lanesU( /+):controlspheroplastswithoutCPT;lanesNaCl( /+):spheroplastspre-treatedwith
0.8MNaCl.AllsampleswereprimerextendedbyVent(exo
 )DNApolymeraseinPCRconditions,startingfrom50 labelledoligor32(forthepositionseeFigure1B).
M:sizemarker(pBR322/MspI);laneAandC:sequencinglanes.PositionsofthetwoDNAtopoisomeraseIcleavagesites( 2236and 2143)areindicatedbyfilled
arrowheads.Numberingreferstothe35Stranscriptionalstartsite(+1).(B)Transcriptiondependence.ComparisonbetweenWTandD43mutant.WTandD43mutant
spheroplasts from exponential coltures were treated with increasing amounts of CPT (filled triangles), as reported for Figure 3.
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cluded that a regular nucleosome structure is present in the
enhancer region. In order to show whether the NTS1 chroma-
tin could be altered in fob1D, we determined nucleosome
positioning by end-labelling analysis (19) comparing the
fob1D strain with the WT strain.
Cells from exponentially growing conditions (0.4 OD/ml)
were treated as reported in ref. (5). Spheroplasts from cells
grown in complete YPD medium, treated with nystatin to
allow permeabilization, were digested with different amounts
of MNase and DNA was puriﬁed. In order to evaluate whether
the nucleosomes were regularly positioned, a speciﬁc restric-
tion with PvuII of the MNase treated samples was coupled to
hybridization with the En probe (mapping in Figure 1). The
DNA fragments were then separated on 1.2% agarose gel and
transferred onto a nitrocellulose ﬁlter by Southern blotting.
The results are reported in Figure 5A. The in vivo treated
samples (Chr) were compared with deproteinized DNA
(which provides the sensitivity of the naked DNA toward
MNase), both of them previously digested with PvuII.
This comparison does not show deﬁned protections thus con-
ﬁrming that nucleosomes in the enhancer region are not orga-
nized as precisely positioned array. This result would also be
compatiblewithnucleosomeabsence,buttheirpresenceinthis
region was demonstrated in a previous work (5).
Whenthesameanalysisreportedabove wasemployedusing
the fob1D mutant, no differences were observed relative to the
WT proﬁle, [compare Figure 5B (fob1D) with A (WT)]. Also
in this experiment no protection from MNase digestion is
visible compared to the naked DNA analysis, so that we
can conclude that nucleosomes in both WT and fob1D mutant
in the enhancer region are not positioned.
Theresults reported in Figure 4and5excludethat the FOB1
dependence of the DNA topoisomerase I cleavage sites is
due to the RFB activity, or to an alteration in the chromatin
organization. Considering the close vicinity of the footprinted
regions and the DNA topoisomerase I cleavage sites (shown in
Figure 2A and B), we conclude that the Fob1p-binding itself
allows DNA topoisomerase I to speciﬁcally cleave DNA at
positions  2143 and  2236.
DISCUSSION
Fob1p acts binding in the enhancer region of the S.cerevisiae
rDNA, where it controls the recombination of the ribosomal
Figure5.ChromatinorganizationoftheNTS1regioninWTandfob1mutantstrains.(A)NystatinpermeabilizedWTspheroplasts(seeMaterialsandMethods)were
treatedwith0.2,0.4,0.8 and1.6 UofMNase(triangles).ThepurifiedDNAwasrestrictedwithPvuII(seeFigure1),transferredontoa nitrocellulosemembraneand
hybridizedwiththeEnprobe(seeFigure1BandMaterialsandMethodsforposition).Lanes1–4:invivodigestedDNA(Chr).Lanes5–8:invitrodigestedsamplesof
deproteinizedDNA(NakedDNA).(B)fob1mutantstrainwasgrownasfortheWTandtheobtainedspheroplastsweretreatedinvivowith0.2,0.4and0.8UofMNase
(triangles). After digestion with PvuII restriction enzyme, the purified DNA was treated as reported for WT and hybridized with the En probe. Lanes 1–3: in vivo
digested DNA (Chr). Lanes 4–6: in vitro digested samples of deproteinized DNA (Naked DNA). Bars and numbers at the left part of each gel, refer to molecular
weight markers positions (1 kb plus ladder). (C) Schematic representation of the enhancer and its surrounding region.
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in vivo binding sites of this protein, within the NTS1 region
oftherDNA.Infact,ithasrecentlybeen demonstratedinvitro,
that this protein is capable to bind, with different efﬁciency,
the three RFB sequences (RFB1-3) lying in the NTS1 tract (9).
Moreover, it has been reported that Fob1p together with Sir2p
and Net1p localizes in vivo both in the NTS1 (enhancer) and
in the NTS2 (35S RNA promoter) although with different
distribution (8). However the in vivo approach utilized (chro-
matin immunoprecipitation) did not provide information with
the nucleotide level resolution due to the method approxima-
tion ranging around 100–200 bp.
Using an in vivo footprinting assay we mapped the binding
sites of the FOB1 gene product, (reported in Figure 2) showing
a good correlation with those mapped in vitro and reported
previuosly (8). As for the in vivo analysis, the best interactions
arebetweenFob1pandtheRFB1and3,respectively,beingthe
RBF2 sequence not bound in vivo and weakly bound in vitro
(compare the graphical scheme in Figure 2C). The most
important output of this ﬁne mapping obtained in vivo,i s
the perception that these footprinted regions nearly overlap
the DNA topoisomerase I cleavage sites that we have deter-
mined previously [also reported in Figure 2B, (13)]. In addi-
tion, we have clariﬁed the absence of interference of SIR2 and
NET1 in Fob1p-binding, observing that the Fob1p footprint, in
sir2D and net1D strains, is similar to the one shown by the WT
cells. Given the proximity between DNA topoisomerase I
cleavage sites in the enhancer region and the binding sites
of Fob1p, we asked the following question: are the cleavage
sites produced by the DNA topoisomerase I in the NTS region
duetothe presence ofthe FOB1 gene, ordo they depend onthe
presence/absence of potential partners like SIR2 and NET1?.
When the study of the cleavage sites was conducted in strains
mutant for SIR2, NET1 or FOB1 respectively, we observed, on
the NTS1 region, a clear dependence on FOB1 of the clea-
vages due to DNA topoisomerase I (Figure 3A). This repre-
sents the ﬁrst observation in which the dependence of these
sites upon a speciﬁc gene is reported. We hypothesize that a
physical interaction, if any, between Fob1p and DNA topoi-
somerase I could be weak; in fact, previous reports (32)
demonstrated that DNA topoisomerase I interacts only with
two gene products, TOF1 and TOF2, strongly enough to be
detectedin an extensive two-hybrids screening.When a Dtof2
mutant was analysed, we observed that the cleavage efﬁciency
was not affected (data not shown) suggesting that TOF2,
described to be present in the RENT complex (33), does
not interfere with the DNA topoisomerase I cleavage activity
on the NTS1 sequence.
In a previous study (13) we found that the absence of tran-
scription does not interfere with the capability of DNA topoi-
somerase I to cleave DNA nearby the 35S RNA promoter
region. Actually, in the promoter region, where a speciﬁc
cleavage site was also shown (13), FOB1 dependence was
not observed, (Figure 3B). This observation conﬁrms the
reported data (8) that consider the existence of two different
mechanisms acting in the recruitment of silencing proteins on
rDNA: one depending on Fob1p, Sir2p and Net1p contacting
the enhancer region and the transcriptional silencing; the other
involving components acting in a speciﬁc manner on rDNA,
probably recruiting RNA polymerase I, as reported previously
(34,35). Our observation implies that these complexes could
contain the DNA topoisomerase I activity, probably weakly
bound and not detected by biochemical assays. The role of
DNA topoisomerase Iinthisregiondoesnotseem toberelated
to rDNA replication, nor to rDNA transcription. In fact, when
we analysed the DNA replication fork blocking activity on the
RFBs and the RNA transcription (both of them proposed as
important events for the induction of DNA recombination, see
(36) we could not ﬁnd any correlation between these processes
and the possible production of alternative DNA topoisomerase
I sites, as reported in Figure 4A and B.
Thus the DNA topoisomerase I cleavage production does
not depend on replication and transcription of rDNA. Since we
demonstrated that the cleavage sites in the enhancer region are
FOB1 dependent, we consider that the most reasonable
explanation relies on the binding of Fob1p itself to DNA
and on the possible consequent distortion of the double
helix due to its binding. In order to verify the involvement
of the chromosomal context on the cleavage efﬁciency of
DNA topoisomerase I on NTS1 sequence, we analysed the
cleavage proﬁle induced by CPT addition in a rdnDD strain
(27) (lacking the whole chromosomal rDNA array) and
containing the pNOY373 plasmid (carrying an entire rDNA
unit). The results exclude an involvement of the chromosomal
context because the ectopic copy of rDNA was cleaved by
DNA topoisomerase I with an efﬁciency comparable to that
one shown by the WT strain. Actually, it has been reported
that bent DNA represents an efﬁcient substrate for DNA topoi-
somerase I (37) and a similar deviation from linearity of the
double helix could be exerted by Fob1p by binding the DNA.
In a previous paper (9) an observation was reported, compa-
tible with the wrapping of DNA around Fob1p, structure that
may produce a signiﬁcant bent in the DNA molecule that DNA
topoisomerase I can recognize and efﬁciently cleave. This
implies that the nicks produced by DNA topoisomerase I
may be the starting points of FOB1 mediated recombination
events. Conversely, the hyper-rec phenotype observed in
top1D strains (15) could be due to a different mechanism
triggered by the accumulation of superhelical stress due to
lack of the swivel activity of DNA topoisomerase I.
It is noteworthy that Net1p and Sir2p associate to DNA both
in the enhancer and in the promoter regions (8). These asso-
ciations are FOB1 dependent at the enhancer and FOB1 inde-
pendent at the promoter. Interestingly, also the DNA
topoisomerase I site-speciﬁc behaviour, reported in this
paper, turns out to be FOB1 dependent at the enhancer and
independent at the promoter (Figure 3). Taken together these
data suggest a possible involvement of DNA topoisomerase I
in the RENT complex with Net1p, Sir2p and CdC14p (25).
Given that Net1p shares signiﬁcant sequence similarity (32)
with Tof2 [Topoisomerase interacting factor 2; (32)] of S.cer-
evisiae, we hypothesize a possible interaction between Net1p
and DNA topoisomerase I according to the previous idea that
DNA topoisomerase I is also part of the RENT complex.
It has been recently reported that ribosomal DNA shows
double strand breaks or nicked forms at positions overlapping
those we found to be DNA topoisomerase I cleavage sites, and
the authors of this work reported these ruptures to be FOB1
dependent (38). We strongly suppose that the nicks reported in
those experiments are actually the cleavage sites produced by
DNA topoisomerase I that we found in this and a previous
paper (13); in addition we observed also the capability of
Nucleic Acids Research, 2005, Vol. 33, No. 19 6335top3D strain to produce the same pattern proﬁle of WT strain
(data not shown). For this reason we may exclude the involve-
ment of DNA topoisomerase III activity [hypothesized in (13)]
for the cleavage production in the regions analysed in our
study.
The ﬁnding of an involvement of Fob1p in the site-speciﬁc
activity of DNA topoisomerase I contributes to clarify the role
of this enzyme in important events occurring in the rDNA such
as the control ofgenomestability,transcriptional silencingand
cellular aging.
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